Formulazione | Dosaggio | Status | Forma farmaceutica |
Ampoules | 0.02 mg/ml (5 ml) | Available |
![]() |
Indicazioni: Linfoma Cutaneo a cellule T (CTCL) |
Ampoules 0.02 mg/ml (5 ml) |
Available |
Indicazioni: Linfoma Cutaneo a cellule T (CTCL) |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Gastro-resistant tablets | 75 mg | Available |
![]() |
Gastro-resistant tablets | 100 mg | Available |
![]() |
Gastro-resistant tablets | 160 mg | Available |
![]() |
Tablets | 75 mg | Available |
![]() |
Tablets | 100 mg | Available |
![]() |
Indicazioni: Antithrombotika |
Gastro-resistant tablets 75 mg |
Available |
Gastro-resistant tablets 100 mg |
Available |
Gastro-resistant tablets 160 mg |
Available |
Tablets 75 mg |
Available |
Tablets 100 mg |
Available |
Indicazioni: Antithrombotika |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Film-coated tablets | 50 mg | Available |
![]() |
Film-coated tablets | 150 mg | Available |
![]() |
Film-coated tablets | 300 mg | Available |
![]() |
Indicazioni: Vitamin B1 Deficiency |
Film-coated tablets 50 mg |
Available |
Film-coated tablets 150 mg |
Available |
Film-coated tablets 300 mg |
Available |
Indicazioni: Vitamin B1 Deficiency |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Film-coated tablets | 10 mg | Q1 2024 |
![]() |
Film-coated tablets | 25 mg | Q1 2024 |
![]() |
Film-coated tablets | 50 mg | Q1 2024 |
![]() |
Film-coated tablets | 75 mg | Q1 2024 |
![]() |
Film-coated tablets | 100 mg | Q1 2024 |
![]() |
Indicazioni: Epilepsy |
Film-coated tablets 10 mg |
Q1 2024 |
Film-coated tablets 25 mg |
Q1 2024 |
Film-coated tablets 50 mg |
Q1 2024 |
Film-coated tablets 75 mg |
Q1 2024 |
Film-coated tablets 100 mg |
Q1 2024 |
Indicazioni: Epilepsy |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Compresse sublinguali | 1 mg | Available |
![]() |
Compresse sublinguali | 2 mg | Available |
![]() |
Compresse sublinguali | 4 mg | Available |
![]() |
Compresse sublinguali | 6 mg | Available |
![]() |
Compresse sublinguali | 8 mg | Available |
![]() |
Compresse sublinguali | 12 mg | Available |
![]() |
Compresse sublinguali | 16 mg | Available |
![]() |
Compresse sublinguali | 0.2 mg | Q2 2023 |
![]() |
Compresse sublinguali | 0.4 mg | Q2 2023 |
![]() |
Indicazioni: Opioid Use Disorder |
Compresse sublinguali 1 mg |
Available |
Compresse sublinguali 2 mg |
Available |
Compresse sublinguali 4 mg |
Available |
Compresse sublinguali 6 mg |
Available |
Compresse sublinguali 8 mg |
Available |
Compresse sublinguali 12 mg |
Available |
Compresse sublinguali 16 mg |
Available |
Compresse sublinguali 0.2 mg |
Q2 2023 |
Compresse sublinguali 0.4 mg |
Q2 2023 |
Indicazioni: Opioid Use Disorder |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Compresse sublinguali | 2 mg+0.5 mg | Available |
![]() |
Compresse sublinguali | 4 mg+1 mg | Available |
![]() |
Compresse sublinguali | 8 mg+2 mg | Available |
![]() |
Compresse sublinguali | 1 mg+0.25 mg | Q4 2023 |
![]() |
Compresse sublinguali | 12 mg+3 mg | Q4 2023 |
![]() |
Compresse sublinguali | 16 mg+4 mg | Q4 2023 |
![]() |
Indicazioni: Opioid Use Disorder |
Compresse sublinguali 2 mg+0.5 mg |
Available |
Compresse sublinguali 4 mg+1 mg |
Available |
Compresse sublinguali 8 mg+2 mg |
Available |
Compresse sublinguali 1 mg+0.25 mg |
Q4 2023 |
Compresse sublinguali 12 mg+3 mg |
Q4 2023 |
Compresse sublinguali 16 mg+4 mg |
Q4 2023 |
Indicazioni: Opioid Use Disorder |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Tablets | 8 mg+12.5 mg | 2024 |
![]() |
Tablets | 16 mg+12.5 mg | 2024 |
![]() |
Tablets | 32 mg+12.5 mg | 2024 |
![]() |
Tablets | 32 mg+25 mg | 2024 |
![]() |
Indicazioni: High Blood Pressure |
Tablets 8 mg+12.5 mg |
2024 |
Tablets 16 mg+12.5 mg |
2024 |
Tablets 32 mg+12.5 mg |
2024 |
Tablets 32 mg+25 mg |
2024 |
Indicazioni: High Blood Pressure |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Solution for injection or infusion | 5 mg/ml (2 ml, 5 ml, 10 ml) | Available |
![]() |
Solution for injection or infusion | 25 mg/ml (2 ml, 5 ml, 10 ml) | Available |
![]() |
Solution for injection or infusion | 5 mg/ml (5 ml, 10 ml, 20 ml) | Available |
![]() |
Solution for injection or infusion | 25 mg/ml (5 ml, 10 ml, 20 ml) | Available |
![]() |
Indicazioni: Narcotic, Severe Pain |
Solution for injection or infusion 5 mg/ml (2 ml, 5 ml, 10 ml) |
Available |
Solution for injection or infusion 25 mg/ml (2 ml, 5 ml, 10 ml) |
Available |
Solution for injection or infusion 5 mg/ml (5 ml, 10 ml, 20 ml) |
Available |
Solution for injection or infusion 25 mg/ml (5 ml, 10 ml, 20 ml) |
Available |
Indicazioni: Narcotic, Severe Pain |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Tablets | 200 mg | Available |
![]() |
Tablets | 400 mg | Available |
![]() |
Tablets | 600 mg | Available |
![]() |
Tablets | 800 mg | Available |
![]() |
Indicazioni: Epilepsy |
Tablets 200 mg |
Available |
Tablets 400 mg |
Available |
Tablets 600 mg |
Available |
Tablets 800 mg |
Available |
Indicazioni: Epilepsy |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Film-coated tablets | 1 mg | Available |
![]() |
Film-coated tablets | 2 mg | Available |
![]() |
Film-coated tablets | 3 mg | Available |
![]() |
Indicazioni: Insomnia |
Film-coated tablets 1 mg |
Available |
Film-coated tablets 2 mg |
Available |
Film-coated tablets 3 mg |
Available |
Indicazioni: Insomnia |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Syrup | 50 mg/ml (250 ml) | - |
![]() |
Indicazioni: Epilepsy |
Syrup 50 mg/ml (250 ml) |
- |
Indicazioni: Epilepsy |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Capsules | 100 mg+20 mg | Dossier update pending |
![]() |
Indicazioni: Anaemia |
Capsules 100 mg+20 mg |
Dossier update pending |
Indicazioni: Anaemia |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Capsules | 66.7 mg+100 mg+0.8 mg | Available |
![]() |
Indicazioni: Anaemia during Pregnancy |
Capsules 66.7 mg+100 mg+0.8 mg |
Available |
Indicazioni: Anaemia during Pregnancy |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Capsules | 50 mg+0.5 mg | Dossier update pending |
![]() |
Indicazioni: Anaemia during Pregnancy |
Capsules 50 mg+0.5 mg |
Dossier update pending |
Indicazioni: Anaemia during Pregnancy |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Film-coated tablets | 20 mg | Available |
![]() |
Film-coated tablets | 40 mg | Available |
![]() |
Indicazioni: Depression |
Film-coated tablets 20 mg |
Available |
Film-coated tablets 40 mg |
Available |
Indicazioni: Depression |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Tablets | 1 mg | Available |
![]() |
Tablets | 5 mg | Available |
![]() |
Indicazioni: Folic Acid Deficiency |
Tablets 1 mg |
Available |
Tablets 5 mg |
Available |
Indicazioni: Folic Acid Deficiency |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Solution for injection | 2 mg/ml (1 ml) | Available |
![]() |
Solution for injection | 10 mg/ml (1 ml, 10 ml) | Available |
![]() |
Solution for injection | 20 mg/ml (1 ml) | Available |
![]() |
Solution for injection | 50 mg/ml (1 ml) | Available |
![]() |
Film-coated tablets | 1.3 mg | Q3 2023 |
![]() |
Film-coated tablets | 2.6 mg | Q3 2023 |
![]() |
Indicazioni: Severe Pain |
Solution for injection 2 mg/ml (1 ml) |
Available |
Solution for injection 10 mg/ml (1 ml, 10 ml) |
Available |
Solution for injection 20 mg/ml (1 ml) |
Available |
Solution for injection 50 mg/ml (1 ml) |
Available |
Film-coated tablets 1.3 mg |
Q3 2023 |
Film-coated tablets 2.6 mg |
Q3 2023 |
Indicazioni: Severe Pain |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Solution for injection | 1 mg/ml (1 ml) | Available |
![]() |
Indicazioni: Vitamin B12 Deficiency |
Solution for injection 1 mg/ml (1 ml) |
Available |
Indicazioni: Vitamin B12 Deficiency |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Solution for injection or infusion | 10 mg/ml (2 ml, 5 ml, 10 ml) | Available |
![]() |
Solution for injection or infusion | 50 mg/ml (2 ml, 5 ml, 10 ml) | Available |
![]() |
Solution for injection or infusion | 10 mg/ml (5 ml, 10 ml, 20 ml) | Available |
![]() |
Solution for injection or infusion | 50 mg/ml (5 ml, 10 ml, 20 ml) | Available |
![]() |
Indicazioni: Narcotic, Severe Pain |
Solution for injection or infusion 10 mg/ml (2 ml, 5 ml, 10 ml) |
Available |
Solution for injection or infusion 50 mg/ml (2 ml, 5 ml, 10 ml) |
Available |
Solution for injection or infusion 10 mg/ml (5 ml, 10 ml, 20 ml) |
Available |
Solution for injection or infusion 50 mg/ml (5 ml, 10 ml, 20 ml) |
Available |
Indicazioni: Narcotic, Severe Pain |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Film-coated tablets | 50 mg | Available |
![]() |
Film-coated tablets | 100 mg | Available |
![]() |
Film-coated tablets | 150 mg | Available |
![]() |
Film-coated tablets | 200 mg | Available |
![]() |
Oral solution | 10 mg/ml (200 ml, 500 ml) | Available |
![]() |
Solution for infusion | 10 mg/ml (10 ml, 20 ml) | Available |
![]() |
Solution for infusion | 10 mg/ml (20 ml) | Available |
![]() |
Indicazioni: Epilepsy |
Film-coated tablets 50 mg |
Available |
Film-coated tablets 100 mg |
Available |
Film-coated tablets 150 mg |
Available |
Film-coated tablets 200 mg |
Available |
Oral solution 10 mg/ml (200 ml, 500 ml) |
Available |
Solution for infusion 10 mg/ml (10 ml, 20 ml) |
Available |
Solution for infusion 10 mg/ml (20 ml) |
Available |
Indicazioni: Epilepsy |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Oral solution | 100 mg/ml (150 ml, 300 ml) | Available |
![]() |
Concentration for solution for infusion | 100 mg/ml (5 ml) | Available |
![]() |
Indicazioni: Epilepsy |
Oral solution 100 mg/ml (150 ml, 300 ml) |
Available |
Concentration for solution for infusion 100 mg/ml (5 ml) |
Available |
Indicazioni: Epilepsy |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Tablets | 2.5 mg | Available |
![]() |
Tablets | 5 mg | Available |
![]() |
Tablets | 10 mg | Available |
![]() |
Tablets | 20 mg | Available |
![]() |
Tablets | 30 mg | Available |
![]() |
Concentration for oral solution | 5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml) | Available |
![]() |
Indicazioni: Opioid Use Disorder |
Tablets 2.5 mg |
Available |
Tablets 5 mg |
Available |
Tablets 10 mg |
Available |
Tablets 20 mg |
Available |
Tablets 30 mg |
Available |
Concentration for oral solution 5 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000ml) |
Available |
Indicazioni: Opioid Use Disorder |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Solution for injection | 500 mg/ml (2 ml, 5 ml) | Available |
![]() |
Film-coated tablets | 500 mg | 2024 |
![]() |
Film-coated tablets | 1000 mg | 2024 |
![]() |
Indicazioni: Mild to Moderate Pain |
Solution for injection 500 mg/ml (2 ml, 5 ml) |
Available |
Film-coated tablets 500 mg |
2024 |
Film-coated tablets 1000 mg |
2024 |
Indicazioni: Mild to Moderate Pain |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Tablets | 5 mg | Available |
![]() |
Tablets | 10 mg | Available |
![]() |
Tablets | 20 mg | Available |
![]() |
Tablets | 40 mg | Available |
![]() |
Tablets | 60 mg | Available |
![]() |
Concentration for oral solution | 10 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000 ml) | Available |
![]() |
Indicazioni: Opioid Use Disorder |
Tablets 5 mg |
Available |
Tablets 10 mg |
Available |
Tablets 20 mg |
Available |
Tablets 40 mg |
Available |
Tablets 60 mg |
Available |
Concentration for oral solution 10 mg/ml (100 ml, 150 ml, 300 ml, 500 ml, 1000 ml) |
Available |
Indicazioni: Opioid Use Disorder |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Oral solution | 1 mg/ml (150 ml) | Available |
![]() |
Solution for injection or infusion | 5 mg/ml (2 ml, 10 ml) | Available |
![]() |
Indicazioni: Emesis, Nausea |
Oral solution 1 mg/ml (150 ml) |
Available |
Solution for injection or infusion 5 mg/ml (2 ml, 10 ml) |
Available |
Indicazioni: Emesis, Nausea |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Solution for injection | 10 mg/ml (1 ml) | Available |
![]() |
Solution for injection | 10 mg/ml (10 ml) | Available |
![]() |
Solution for injection | 20 mg/ml (10 ml) | Available |
![]() |
Indicazioni: Severe Pain |
Solution for injection 10 mg/ml (1 ml) |
Available |
Solution for injection 10 mg/ml (10 ml) |
Available |
Solution for injection 20 mg/ml (10 ml) |
Available |
Indicazioni: Severe Pain |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Film-coated tablets | 5 mg | Available |
![]() |
Film-coated tablets | 10 mg | Available |
![]() |
Film-coated tablets | 20 mg | Available |
![]() |
Prolonged-release tablets | 5 mg | Available |
![]() |
Prolonged-release tablets | 10 mg | Available |
![]() |
Prolonged-release tablets | 15 mg | Available |
![]() |
Prolonged-release tablets | 20 mg | Available |
![]() |
Prolonged-release tablets | 30 mg | Available |
![]() |
Prolonged-release tablets | 40 mg | Available |
![]() |
Prolonged-release tablets | 60 mg | Available |
![]() |
Prolonged-release tablets | 80 mg | Available |
![]() |
Oral solution | 1 mg/ml (100 ml, 250 ml, 300 ml) | Available |
![]() |
Oral solution | 10 mg/ml (30 ml, 100 ml, 120 ml) | Available |
![]() |
Solution for injection or infusion | 10 mg/ml (1 ml, 2 ml) | Available |
![]() |
Indicazioni: Severe Pain |
Film-coated tablets 5 mg |
Available |
Film-coated tablets 10 mg |
Available |
Film-coated tablets 20 mg |
Available |
Prolonged-release tablets 5 mg |
Available |
Prolonged-release tablets 10 mg |
Available |
Prolonged-release tablets 15 mg |
Available |
Prolonged-release tablets 20 mg |
Available |
Prolonged-release tablets 30 mg |
Available |
Prolonged-release tablets 40 mg |
Available |
Prolonged-release tablets 60 mg |
Available |
Prolonged-release tablets 80 mg |
Available |
Oral solution 1 mg/ml (100 ml, 250 ml, 300 ml) |
Available |
Oral solution 10 mg/ml (30 ml, 100 ml, 120 ml) |
Available |
Solution for injection or infusion 10 mg/ml (1 ml, 2 ml) |
Available |
Indicazioni: Severe Pain |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Prolonged-release tablets | 5 mg+2.5 mg | Available |
![]() |
Prolonged-release tablets | 10 mg+5 mg | Available |
![]() |
Prolonged-release tablets | 20 mg+10 mg | Available |
![]() |
Prolonged-release tablets | 30 mg+15 mg | Available |
![]() |
Prolonged-release tablets | 40 mg+20 mg | Available |
![]() |
Indicazioni: Severe Pain |
Prolonged-release tablets 5 mg+2.5 mg |
Available |
Prolonged-release tablets 10 mg+5 mg |
Available |
Prolonged-release tablets 20 mg+10 mg |
Available |
Prolonged-release tablets 30 mg+15 mg |
Available |
Prolonged-release tablets 40 mg+20 mg |
Available |
Indicazioni: Severe Pain |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Film-coated tablets | 2 mg | Available |
![]() |
Film-coated tablets | 4 mg | Available |
![]() |
Film-coated tablets | 6 mg | Available |
![]() |
Film-coated tablets | 8 mg | Available |
![]() |
Film-coated tablets | 10 mg | Available |
![]() |
Film-coated tablets | 12 mg | Available |
![]() |
Indicazioni: Epilepsy |
Film-coated tablets 2 mg |
Available |
Film-coated tablets 4 mg |
Available |
Film-coated tablets 6 mg |
Available |
Film-coated tablets 8 mg |
Available |
Film-coated tablets 10 mg |
Available |
Film-coated tablets 12 mg |
Available |
Indicazioni: Epilepsy |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Tablets | 65 mg | Available |
![]() |
Indicazioni: Radiation Prophylaxis |
Tablets 65 mg |
Available |
Indicazioni: Radiation Prophylaxis |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Film-coated tablets | 25 mg | Available |
![]() |
Film-coated tablets | 50 mg | Available |
![]() |
Film-coated tablets | 75 mg | Available |
![]() |
Film-coated tablets | 100 mg | Available |
![]() |
Oral solution | 20 mg/ml (100 ml, 200 ml) | Available |
![]() |
Prolonged-release tablets | 25 mg | Available |
![]() |
Prolonged-release tablets | 50 mg | Available |
![]() |
Prolonged-release tablets | 100 mg | Available |
![]() |
Prolonged-release tablets | 150 mg | Available |
![]() |
Prolonged-release tablets | 200 mg | Available |
![]() |
Prolonged-release tablets | 250 mg | Available |
![]() |
Indicazioni: Severe Pain |
Film-coated tablets 25 mg |
Available |
Film-coated tablets 50 mg |
Available |
Film-coated tablets 75 mg |
Available |
Film-coated tablets 100 mg |
Available |
Oral solution 20 mg/ml (100 ml, 200 ml) |
Available |
Prolonged-release tablets 25 mg |
Available |
Prolonged-release tablets 50 mg |
Available |
Prolonged-release tablets 100 mg |
Available |
Prolonged-release tablets 150 mg |
Available |
Prolonged-release tablets 200 mg |
Available |
Prolonged-release tablets 250 mg |
Available |
Indicazioni: Severe Pain |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Tablets | 2 mg | Available |
![]() |
Tablets | 4 mg | Available |
![]() |
Tablets | 6 mg | Available |
![]() |
Indicazioni: Muscle Spasms |
Tablets 2 mg |
Available |
Tablets 4 mg |
Available |
Tablets 6 mg |
Available |
Indicazioni: Muscle Spasms |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Solution for injection | 50 mg/ml (2 ml) | Dossier update pending |
![]() |
Oral drops | 100 mg/ml (10 ml, 30 ml, 50 ml) | Dossier update pending |
![]() |
Indicazioni: Moderate to Severe Pain |
Solution for injection 50 mg/ml (2 ml) |
Dossier update pending |
Oral drops 100 mg/ml (10 ml, 30 ml, 50 ml) |
Dossier update pending |
Indicazioni: Moderate to Severe Pain |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Oral solution | 10 mg/ml (120 ml) | Available |
![]() |
Prolonged-release tablets | 75 mg | 2025 |
![]() |
Prolonged-release tablets | 150 mg | 2025 |
![]() |
Indicazioni: Depression |
Oral solution 10 mg/ml (120 ml) |
Available |
Prolonged-release tablets 75 mg |
2025 |
Prolonged-release tablets 150 mg |
2025 |
Indicazioni: Depression |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Oral solution | 300 mg/ml (100 ml) | Available |
![]() |
Prolonged-release tablets | 300 mg | 2024 |
![]() |
Prolonged-release tablets | 500 mg | 2024 |
![]() |
Gastro-resistant soft capsules | 150 mg | Dossier update pending |
![]() |
Gastro-resistant soft capsules | 300 mg | Dossier update pending |
![]() |
Gastro-resistant soft capsules | 500 mg | Dossier update pending |
![]() |
Syrup | 50 mg/ml (100 ml) | Dossier update pending |
![]() |
Solution for injection | 100 mg/ml (5 ml) | Dossier update pending |
![]() |
Indicazioni: Epilepsy |
Oral solution 300 mg/ml (100 ml) |
Available |
Prolonged-release tablets 300 mg |
2024 |
Prolonged-release tablets 500 mg |
2024 |
Gastro-resistant soft capsules 150 mg |
Dossier update pending |
Gastro-resistant soft capsules 300 mg |
Dossier update pending |
Gastro-resistant soft capsules 500 mg |
Dossier update pending |
Syrup 50 mg/ml (100 ml) |
Dossier update pending |
Solution for injection 100 mg/ml (5 ml) |
Dossier update pending |
Indicazioni: Epilepsy |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Film-coated tablets | 100 mg+200 mg+0.2 mg | Dossier update pending |
![]() |
Solution for injection | 50 mg+50 mg+0.5 mg/ml (2 ml) | Dossier update pending |
![]() |
Indicazioni: Neuropathic Pain, Vitamin B Deficiency |
Film-coated tablets 100 mg+200 mg+0.2 mg |
Dossier update pending |
Solution for injection 50 mg+50 mg+0.5 mg/ml (2 ml) |
Dossier update pending |
Indicazioni: Neuropathic Pain, Vitamin B Deficiency |
Formulazione | Dosaggio | Status | Forma farmaceutica |
Oral solution | 14 400 IU/ml (12.5 ml, 30 ml) | Available |
![]() |
Oral solution | 28 800 IU/ml (12.5 ml, 30 ml, 50 ml) | Available |
![]() |
Indicazioni: Vitamin D3 Deficiency |
Oral solution 14 400 IU/ml (12.5 ml, 30 ml) |
Available |
Oral solution 28 800 IU/ml (12.5 ml, 30 ml, 50 ml) |
Available |
Indicazioni: Vitamin D3 Deficiency |
Per qualunque domanda contattaci senza esitare.